Global Dry Eye Disease Diagnostics & Treatment Market Size, Share, Forecast Report, 2020-2027

The global Dry Eye Disease Diagnostics & Treatment market garnered revenue around USD 6.2 Billion in 2019 and projected to reach USD 9.7 Billion in 2027, with at a compound annual growth rate (CAGR) 4.2% throughout the estimate period from 2020 to 2027. Dry eye is one of the common problems, which occurs when eyes do not produce enough tears. Several factors can cause dry eyes such as natural aging process and side effects of certain drugs such as histamines. Diabetes increases the risk of dry eye disease. Moreover, people who wear contact lenses complain of dry eye diseases. Dry eye is caused due to tear deficiency or excessive evaporation, which causes damage to the interpalpebral ocular surface and is associated with symptoms of ocular discomfort. Different diagnostic tests are performed for diagnosis of dry eye disease such as Schirmer’s test, corneal staining, and tear osmolarity. Treatment options for dry eye include artificial tears, anti-inflammatory drugs, and secretagogue.

North America dominated the global dry eye disease diagnostics & treatment market in 2019. It is expected to dominate the global market in terms of revenue during the forecast period.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Dry Eye Disease Diagnostics & Treatment market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Dry Eye Disease Diagnostics & Treatment market growth.

The global Dry Eye Disease Diagnostics & Treatment market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global market include Novartis AG, Allergan plc, OASIS Medical, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Tomey Corporation, Carl Zeiss Meditec AG, TearLab Corporation, Bausch Health Companies, Inc., and RegeneRx (ReGenTree, LLC). Mergers

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Dry Eye Disease Diagnostics & Treatment Market: Segmentation

• Dry Eye Disease Diagnostics & Treatment Market, by Type
  • Diagnostic Test
    • Schirmer's Test
    • Corneal Staining
    • Tear Break-up Time (TBUT)
    • Optical Coherence Topography (OCT)
    • Tear Film Stability Analysis
    • Tear Osmolarity
    • Others
  • Treatment
    • Artificial Tears
    • Anti-inflammatory
      • Cyclosporine
      • Corticosteroids
      • Others
    • Secretagogue
    • Punctal Plugs
    • Others
  • Dry Eye Disease Diagnostics & Treatment Market, by Disease
    • Evaporative Dry Eye Syndrome
    • Aqueous Dry Eye Syndrome

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA